Cargando…
LOCL-07 LOCO-REGIONAL INFUSION OF GB-13 (IL13.E13K-PE4E) AS A POTENTIALLY PROMISING TREATMENT FOR RECURRENT HIGH-GRADE GLIOMA
INTRODUCTION: High grade gliomas (HGG) are devastating diseases with largely unchanged survival outcomes despite decades of research. Recent studies suggest the interleukin 13 receptor subunit alpha 2 (IL-13Rα2) is selectively upregulated in up to 80% of HGG, including glioblastoma (GBM) and diffuse...
Autores principales: | Rechberger, Julian, Khatua, Soumen, Campian, Jian, Sarkaria, Jann, Schwartz, Jonathan, Daniels, David, Schrecengost, Randy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354186/ http://dx.doi.org/10.1093/noajnl/vdac078.049 |
Ejemplares similares
-
HGG-10. Efficacy of convection-enhanced delivery of GB-13 (IL13.E13K-PE4E) in an orthotopic xenograft model of high-grade glioma is predicated on IL-13Rα2 expression.
por: Rechberger, Julian, et al.
Publicado: (2022) -
IL-13Rα2 Status Predicts GB-13 (IL13.E13K-PE4E) Efficacy in High-Grade Glioma
por: Rechberger, Julian S., et al.
Publicado: (2022) -
DIPG-15. CONCURRENT GB-13 (IL13.E13K-PE4E) IMPROVES THE EFFICACY OF RADIATION THERAPY IN DIFFUSE INTRINSIC PONTINE GLIOMA
por: Rechberger, Julian S, et al.
Publicado: (2023) -
EXM 86-13: 10/07/1986
por: Malandain, E, et al.
Publicado: (1986) -
EXM 92-13 30/07/92
por: Daems, G
Publicado: (1992)